Alejandro J Cagnoni

6PUBLICATIONS
30CO-AUTHORS
AutoimmunityBiologically active moleculesGene and molecular therapyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 10, 2025
Design of galectin-1-conjugated nanoparticles as potential immunomodulatory agents.

Chandradhish Ghosh, Ling Yao, Marilet Sigler

|Aug 01, 2024
The sunflower jacalin Helja: biological and structural insights of its antifungal activity against Candida albicans.

Marianela V Del Río, Melisa B Radicioni, Anabela M Cutine

|Jan 12, 2023
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.

Nadia Bannoud, Juan C Stupirski, Alejandro J Cagnoni

|Jun 19, 2021
Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits.

Luciano G Morosi, Anabela M Cutine, Alejandro J Cagnoni

|May 19, 2021
Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.

Alejandro J Cagnoni, María Laura Giribaldi, Ada G Blidner

|Nov 02, 2020
Crystal structures of peanut lectin in the presence of synthetic β-N- and β-S-galactosides disclose evidence for the recognition of different glycomimetic ligands.

Alejandro J Cagnoni, Emiliano D Primo, Sebastián Klinke

Pageof 1

Frequent Collaborators

5 joint publications

Karina V Mariño

3 joint publications

Diego O Croci

3 joint publications

Anabela M Cutine

1 joint publications

Emiliano D Primo